{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:43:57Z","timestamp":1759538637039,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.tox.2016.12.009","type":"journal-article","created":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T19:51:08Z","timestamp":1483473068000},"page":"73-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Lymphocytes contribute to biliary injury and fibrosis in experimental xenobiotic-induced cholestasis"],"prefix":"10.1016","volume":"377","author":[{"given":"Nikita","family":"Joshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna K.","family":"Kopec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly","family":"Cline-Fedewa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"Luyendyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2016.12.009_bib0005","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/0041-008X(65)90125-0","article-title":"The nature of alpha-naphthylisothiocyanate-induced cholestasis","volume":"7","author":"Becker","year":"1965","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2016.12.009_bib0010","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1172\/JCI26845","article-title":"B cells: no longer bystanders in liver fibrosis","volume":"115","author":"Bhogal","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tox.2016.12.009_bib0015","first-page":"475","article-title":"Lymphocytes from patients with primary biliary cirrhosis spontaneously secrete high levels of IgG3 in culture","volume":"71","author":"Bird","year":"1988","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.tox.2016.12.009_bib0020","first-page":"1106","article-title":"Blood and liver-infiltrating lymphocytes in primary biliary cirrhosis: increase in activated T and natural killer cells and recruitment of primed memory T cells","volume":"13","author":"Bjorkland","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.tox.2016.12.009_bib0025","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.3748\/wjg.v11.i27.4167","article-title":"Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligation","volume":"11","author":"Chang","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tox.2016.12.009_bib0030","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/icb.2008.37","article-title":"The immunobiology of cholangiocytes","volume":"86","author":"Chen","year":"2008","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.tox.2016.12.009_bib0035","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0022-3565(25)23054-3","article-title":"An antibody to neutrophils attenuates alpha-naphthylisothiocyanate-induced liver injury","volume":"256","author":"Dahm","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"year":"2010","series-title":"Alpha-Naphthylisothiocyanate","author":"Dahm","key":"10.1016\/j.tox.2016.12.009_bib0040"},{"key":"10.1016\/j.tox.2016.12.009_bib0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0300-483X(01)00459-0","article-title":"Role of MRP2 and GSH in intrahepatic cycling of toxins","volume":"167","author":"Dietrich","year":"2001","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2016.12.009_bib0050","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2004.04.009","article-title":"Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice","volume":"127","author":"Fickert","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tox.2016.12.009_bib0055","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.etp.2012.12.001","article-title":"Slowly progressive cholangiofibrosis induced in rats by alpha-naphthylisothiocyanate (ANIT), with particular references to characteristics of macrophages and myofibroblasts","volume":"65","author":"Golbar","year":"2013","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.tox.2016.12.009_bib0060","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/pr.2012.17","article-title":"Combinatory effects of hepatic CD8+ and NK lymphocytes in bile duct injury from biliary atresia","volume":"71","author":"Guo","year":"2012","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.tox.2016.12.009_bib0065","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2353\/ajpath.2007.060158","article-title":"Alphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouse","volume":"170","author":"Hahm","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tox.2016.12.009_bib0070","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/toxsci\/47.1.118","article-title":"Bile duct epithelial cells exposed to alpha-naphthylisothiocyanate produce a factor that causes neutrophil-dependent hepatocellular injury in vitro","volume":"47","author":"Hill","year":"1999","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2016.12.009_bib0075","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","article-title":"Primary sclerosing cholangitis","volume":"382","author":"Hirschfield","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.tox.2016.12.009_bib0080","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/0006-2952(95)02051-9","article-title":"Naphthylisothiocyanate disposition in bile and its relationship to liver glutathione and toxicity","volume":"50","author":"Jean","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2016.12.009_bib0085","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0006-2952(94)00469-2","article-title":"1-naphthylisothiocyanate-induced elevation of biliary glutathione","volume":"49","author":"Jean","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2016.12.009_bib0090","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1124\/jpet.113.210880","article-title":"The antifibrinolytic drug tranexamic acid reduces liver injury and fibrosis in a mouse model of chronic bile duct injury","volume":"349","author":"Joshi","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2016.12.009_bib0095","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/jth.12770","article-title":"Coagulation-driven platelet activation reduces cholestatic liver injury and fibrosis in mice","volume":"13","author":"Joshi","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.tox.2016.12.009_bib0100","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1182\/blood-2015-09-670703","article-title":"Fibrin deposition following bile duct injury limits fibrosis through an alphaMbeta2-dependent mechanism","volume":"127","author":"Joshi","year":"2016","journal-title":"Blood"},{"issue":"September 8","key":"10.1016\/j.tox.2016.12.009_bib0105","article-title":"Dose-dependent effects of alpha-naphthylisothiocyanate disconnect biliary fibrosis from hepatocellular necrosis","author":"Joshi","year":"2016","journal-title":"J. Biochem. Mol. Toxicol."},{"year":"2010","series-title":"Anatomy and Physiology of the Biliary Epithelium","author":"Kanz","key":"10.1016\/j.tox.2016.12.009_bib0110"},{"key":"10.1016\/j.tox.2016.12.009_bib0115","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/jth.13327","article-title":"Role of hemostatic factors in hepatic injury and disease: animal models de-liver","volume":"14","author":"Kopec","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.tox.2016.12.009_bib0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/faat.1995.1074","article-title":"Biliary epithelial cell proliferation following alpha-naphthylisothiocyanate (ANIT) treatment: relationship to bile duct obstruction","volume":"26","author":"Kossor","year":"1995","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2016.12.009_bib0125","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.mayocp.2015.03.017","article-title":"The cholangiopathies","volume":"90","author":"Lazaridis","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.tox.2016.12.009_bib0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-2004-823099","article-title":"The pathology of cholestasis","volume":"24","author":"Li","year":"2004","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.tox.2016.12.009_bib0135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.tox.2016.12.009_bib0140","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ajg.2015.112","article-title":"ACG clinical guideline: primary sclerosing cholangitis","volume":"110","author":"Lindor","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.tox.2016.12.009_bib0145","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.ajpath.2010.11.064","article-title":"Fibrinogen deficiency increases liver injury and early growth response-1 (Egr-1) expression in a model of chronic xenobiotic-induced cholestasis","volume":"178","author":"Luyendyk","year":"2011","journal-title":"Am. J. Pathol."},{"year":"2010","series-title":"Introduction to the Liver and Its Response to Toxicants","author":"McCuskey","key":"10.1016\/j.tox.2016.12.009_bib0150"},{"key":"10.1016\/j.tox.2016.12.009_bib0155","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0092-8674(92)90030-G","article-title":"RAG-1-deficient mice have no mature B and T lymphocytes","volume":"68","author":"Mombaerts","year":"1992","journal-title":"Cell"},{"issue":"Suppl. (1)","key":"10.1016\/j.tox.2016.12.009_bib0160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/jgh.12022","article-title":"Vascular biology of the biliary epithelium","volume":"28","author":"Morell","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tox.2016.12.009_bib0165","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0092-8674(00)80545-0","article-title":"The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis","volume":"96","author":"Munger","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.tox.2016.12.009_bib0170","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2012.10.011","article-title":"The dynamic biliary epithelia: molecules, pathways, and disease","volume":"58","author":"O'Hara","year":"2013","journal-title":"J. Hepatol."},{"issue":"Suppl. (1)","key":"10.1016\/j.tox.2016.12.009_bib0175","first-page":"S79","article-title":"Molecular mechanisms of hepatic fibrogenesis","volume":"22","author":"Parsons","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tox.2016.12.009_bib0180","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2008.04.009","article-title":"Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression","volume":"135","author":"Patsenker","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tox.2016.12.009_bib0185","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3748\/wjg.15.1677","article-title":"Bile-acid-induced cell injury and protection","volume":"15","author":"Perez","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tox.2016.12.009_bib0190","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0031-6997(25)06713-4","article-title":"Intrahepatic cholestasis induced by drugs and chemicals","volume":"28","author":"Plaa","year":"1976","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.tox.2016.12.009_bib0195","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jhep.2005.06.025","article-title":"Mdr2 (Abcb4)-\/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes","volume":"43","author":"Popov","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tox.2016.12.009_bib0200","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2007.11.021","article-title":"Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies","volume":"48","author":"Popov","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tox.2016.12.009_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000366100","article-title":"The immunomodulatory role of bile acids","volume":"165","author":"Sipka","year":"2014","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.tox.2016.12.009_bib0210","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.2353\/ajpath.2010.100425","article-title":"The coagulation system contributes to alphaVbeta6 integrin expression and liver fibrosis induced by cholestasis","volume":"177","author":"Sullivan","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tox.2016.12.009_bib0215","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/toxsci\/kfr311","article-title":"Early growth response factor-1 limits biliary fibrosis in a model of xenobiotic-induced cholestasis in mice","volume":"126","author":"Sullivan","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2016.12.009_bib0220","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/hep.510310204","article-title":"Progressive development of a Th1-type hepatic cytokine profile in rats with experimental cholangitis","volume":"31","author":"Tjandra","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.tox.2016.12.009_bib0225","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJM199810223391707","article-title":"Molecular pathogenesis of cholestasis","volume":"339","author":"Trauner","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tox.2016.12.009_bib0230","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/hep.21849","article-title":"Role of alphavbeta6 integrin in acute biliary fibrosis","volume":"46","author":"Wang","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.tox.2016.12.009_bib0235","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.tox.2016.12.009_bib0240","doi-asserted-by":"crossref","first-page":"G734","DOI":"10.1152\/ajpgi.00300.2003","article-title":"Limited role for CXC chemokines in the pathogenesis of alpha-naphthylisothiocyanate-induced liver injury","volume":"287","author":"Xu","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X16303419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X16303419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:35:17Z","timestamp":1759534517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X16303419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":48,"alternative-id":["S0300483X16303419"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2016.12.009","relation":{},"ISSN":["0300-483X"],"issn-type":[{"type":"print","value":"0300-483X"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphocytes contribute to biliary injury and fibrosis in experimental xenobiotic-induced cholestasis","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2016.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}